KENGREAL 50 mg/1 (Cangrelor INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION) 50 mg/1

Kengreal 50 mg/1 is a lyophilized powder for solution, used for intravenous administration. This medication is indicated for specific cardiovascular procedures to reduce the risk of periprocedural ischemic complications.

Strength

50 mg/1

Pack Size

10 VIAL, SINGLE-USE in 1 CARTON (10122-620-10) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in

Manufacturer / TM Owner

Chiesi USA, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Kengreal is primarily used in patients undergoing percutaneous coronary intervention (PCI) to reduce the risk of periprocedural ischemic complications. It is often employed in procedures where antiplatelet therapy is required to prevent blood clots. The medication is designed to provide rapid and reversible antiplatelet effects, making it suitable for use during cardiovascular interventions.

Side Effects

Common effects of Kengreal may include bleeding at the injection site or other areas of the body. Some patients might experience dizziness or nausea. These effects are generally mild and transient, but any persistent or severe symptoms should be reported to a healthcare provider.

Precautions & Warnings

Kengreal should be handled with care, ensuring proper storage and preparation. It is important to follow the instructions for reconstitution and administration to maintain its efficacy. Patients with a history of bleeding disorders or those taking other anticoagulants should use this medication under medical supervision.

Avoid Interactions

Kengreal may interact with other anticoagulants or antiplatelet drugs, increasing the risk of bleeding. It is important to inform healthcare providers about all medications being taken, including over-the-counter drugs and supplements, to avoid potential interactions.

References

Frequently Asked Questions

Kengreal is used to reduce the risk of periprocedural ischemic complications in patients undergoing percutaneous coronary intervention (PCI).

Kengreal is administered intravenously as a lyophilized powder that is reconstituted into a solution before use.

Common side effects may include bleeding at the injection site, dizziness, and nausea.

Kengreal may interact with other anticoagulants or antiplatelet drugs, so it is important to consult a healthcare provider before combining medications.

Patients with a history of bleeding disorders or those taking other anticoagulants should use Kengreal with caution and under medical supervision.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.